ES2172006T3 - Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium. - Google Patents

Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium.

Info

Publication number
ES2172006T3
ES2172006T3 ES97944746T ES97944746T ES2172006T3 ES 2172006 T3 ES2172006 T3 ES 2172006T3 ES 97944746 T ES97944746 T ES 97944746T ES 97944746 T ES97944746 T ES 97944746T ES 2172006 T3 ES2172006 T3 ES 2172006T3
Authority
ES
Spain
Prior art keywords
preparation
extract
same
parthenium
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97944746T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Eurovita AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurovita AS filed Critical Eurovita AS
Application granted granted Critical
Publication of ES2172006T3 publication Critical patent/ES2172006T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un extracto de Parthenium integrifolium, obtenido mediante extracción de la planta o partes de la misma con un disolvente orgánico miscible en agua o una mezcla del mismo con agua.
ES97944746T 1996-10-21 1997-10-20 Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium. Expired - Lifetime ES2172006T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK115896 1996-10-21
US3139596P 1996-11-19 1996-11-19

Publications (1)

Publication Number Publication Date
ES2172006T3 true ES2172006T3 (es) 2002-09-16

Family

ID=26065310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97944746T Expired - Lifetime ES2172006T3 (es) 1996-10-21 1997-10-20 Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium.

Country Status (10)

Country Link
US (1) US6217877B1 (es)
EP (1) EP1007067B1 (es)
JP (1) JP4346685B2 (es)
AT (1) ATE211918T1 (es)
AU (1) AU711019B2 (es)
DE (1) DE69709691T2 (es)
DK (1) DK1007067T3 (es)
ES (1) ES2172006T3 (es)
PT (1) PT1007067E (es)
WO (1) WO1998017292A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277978B1 (en) 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
WO2002017896A2 (en) 2000-08-29 2002-03-07 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
WO2002047706A2 (en) * 2000-12-15 2002-06-20 Pharmacia Corporation Selective cox-2 inhibition from plant extracts
US7758582B2 (en) * 2002-06-14 2010-07-20 Smith & Nephew, Inc. Device and methods for placing external fixation elements
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
TWI344959B (en) * 2003-04-02 2011-07-11 Nat Health Research Institutes Treatment of hepatitis c virus infection with sesquiterpene lactones
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
EP1829874B1 (en) * 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
WO2006099359A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
WO2006099325A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
KR20070113281A (ko) * 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
US7985734B2 (en) * 2006-06-01 2011-07-26 Yun Cheng Peptides for preventing or treating liver damage
CN104721602A (zh) * 2013-12-19 2015-06-24 汤丽娟 一种治疗腹型偏头痛的中药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
DE3638715A1 (de) * 1986-11-13 1988-05-26 Lohmann Rudolf Lomapharm Sesquiterpenverbindungen, verfahren zu ihrer isolierung und arzneimittel, enthaltend diese verbindungen
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
WO1993013787A1 (en) * 1987-03-27 1993-07-22 Michio Fujimaki Immunopotentiating agent

Also Published As

Publication number Publication date
PT1007067E (pt) 2002-07-31
EP1007067A1 (en) 2000-06-14
EP1007067B1 (en) 2002-01-16
AU4615897A (en) 1998-05-15
DK1007067T3 (da) 2002-05-06
DE69709691T2 (de) 2002-08-22
JP2001501919A (ja) 2001-02-13
JP4346685B2 (ja) 2009-10-21
WO1998017292A1 (en) 1998-04-30
ATE211918T1 (de) 2002-02-15
US6217877B1 (en) 2001-04-17
DE69709691D1 (de) 2002-02-21
AU711019B2 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
ES2172006T3 (es) Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium.
BR9702309A (pt) Uso composição cosmética ou farmacêutica e processo de tratamento cosmético
GEP20022788B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
AU6314596A (en) Pharmaceutical compositions containing herbal-based active ingredients; method for preparing same and uses of same for medical and veterinary purposes
ES2118630T3 (es) Composicion que contiene un aerogel, procedimiento para su preparacion, asi como su empleo.
FI964681A (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
EP0732930A4 (en) COMPOSITIONS INHIBITING APOPTOSIS, METHODS OF PURIFICATION, AND USES THEREOF
ES2147551T3 (es) Procedimiento para transformar plantas monocotiledoneas.
ATE320432T1 (de) Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten
HN2008000727A (es) Composiciones farmaceutica antimastitica de origen natural
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
AU688650B2 (en) Cosmetic kaolin-containing preparation
IN1997DE01715A (es)
DE60117606D1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
BR9607967A (pt) Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
ES2184870T3 (es) Composiciones insecticidas para pulverizar en aerosol.
DK1077725T3 (da) Topiske farmaceutiske sammensætninger til behandling af hudsygdomme eller kredslöbssygdomme på inflammatorisk, immun eller proliferativ eller degenerativ basis omfattende pollenekstrakt og uforsæbelig vegetabilsk olie
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
YU7196A (sh) Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida
PT804182E (pt) Utilizacao de gabapentina para o tratamento da ansiedade e do panico
ATE45373T1 (de) Zusatzmittel enthaltende anstriche.
BR9608396A (pt) Sistema de gelação que compreende a goma carragenana e o endosperma do coco
ZA867568B (en) Derivatives of thiochroman, its preparation and the pharmaceutical compositions containing it
RO103501A2 (en) Medicinal mouth water concentrate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1007067

Country of ref document: ES